1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression
Sadaoki Sakai(Keio University), Yoshiaki Toyama(Keio University), Ayako Shiraishi, Hironari Takaishi(Keio University), Toshio Suda(Chinese Academy of Sciences), Takeshi Miyamoto(Kumamoto Health Science University), Mitsuru Furukawa(Keio University), Kenichiro MATSUZAKI(Kindai University), Tadatsugu Taniguchi(The University of Tokyo), Yoshiteru Miyauchi(Mitsubishi Chemical (Japan)), Hironori Kaneko(Toho University), Keiji Saito(Kyoto University), Akio Tanaka(Hiroshima University)
Cited by 60
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899